• News

Myeloma Patients Who Relapse After CAR T-Cell Therapy Have Options

  • MedPage Today
  • New York, NY
  • (November 04, 2022)

Samir Parekh, MD, and, Oliver Van Oekelen, MD, PhD, discuss their study finding that therapies that engage T cells—a type of white blood cell that protects the body from infection—could provide benefits for patients with relapsed or refractory multiple myeloma, a cancer of the plasma cells.

Learn more